Nicollet Investment Management, Inc. - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 334 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.

Quarter-by-quarter ownership
Nicollet Investment Management, Inc. ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$393
+9.5%
8,668
-1.0%
0.18%
+10.0%
Q2 2023$359
+18.5%
8,758
+3.5%
0.16%
+1.3%
Q1 2023$303
+1.0%
8,465
+6.6%
0.16%
-8.7%
Q4 2022$300
-99.9%
7,938
-6.7%
0.17%
-16.0%
Q3 2022$376,000
+20.1%
8,508
+0.8%
0.21%
+21.9%
Q2 2022$313,000
+2.3%
8,442
+2.1%
0.17%
+24.3%
Q1 2022$306,000
+18.1%
8,269
-2.8%
0.14%
+30.8%
Q4 2021$259,000
-26.4%
8,504
-19.0%
0.10%
-29.7%
Q3 2021$352,000
-16.0%
10,501
-0.0%
0.15%
-13.5%
Q2 2021$419,000
-13.8%
10,504
-2.8%
0.17%
-19.7%
Q1 2021$486,000
-21.0%
10,811
-0.5%
0.21%
-22.8%
Q4 2020$615,000
+25.0%
10,869
+4.9%
0.28%
+10.8%
Q3 2020$492,000
-19.7%
10,361
-0.3%
0.25%
-27.0%
Q2 2020$613,000
+29.6%
10,390
+3.8%
0.34%
-2.8%
Q1 2020$473,000
-24.3%
10,005
-3.2%
0.35%
+20.2%
Q4 2019$625,000
-1.9%
10,340
-2.7%
0.29%
-27.7%
Q3 2019$637,000
-6.0%
10,630
+0.7%
0.40%
-4.9%
Q2 2019$678,000
-21.3%
10,555
-0.7%
0.42%
-25.0%
Q1 2019$862,000
+50.4%
10,625
+0.3%
0.57%
+25.2%
Q4 2018$573,000
+4.0%
10,595
-0.9%
0.45%
+26.2%
Q3 2018$551,000
+29.0%
10,690
+4.2%
0.36%
+16.6%
Q2 2018$427,000
-2.3%
10,255
+3.3%
0.31%
-9.1%
Q1 2018$437,000
-12.2%
9,925
+0.3%
0.34%
-17.1%
Q4 2017$498,0009,8950.41%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Tweedy, Browne Co LLC 3,510,173$159,221,4478.52%
Bellevue Group AG 9,233,700$418,840,6326.75%
Deep Track Capital, LP 2,834,069$128,553,3704.96%
BVF INC/IL 4,004,613$181,649,2464.90%
Sicart Associates LLC 203,132$9,214,0683.61%
Camber Capital Management LP 2,250,000$102,0603.36%
Privium Fund Management B.V. 228,493$10,364,4433.08%
Orbimed Advisors 2,169,500$98,408,5202.09%
SECTOR GAMMA AS 165,616$7,512,3421.92%
TANAKA CAPITAL MANAGEMENT INC 14,612$6631.89%
View complete list of IONIS PHARMACEUTICALS INC shareholders